CIRCULATING MACROPHAGE-TUMOR CELL FUSION HYBRIDS AS A BIOMARKER FOR TREATMENT RESPONSE IN LUNG CANCER

$154,000FY2017Department of the ArmyDOD

Oregon Health & Science University, Portland OR

Investigators